Dr. Bhimraj is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin St
Ste 1540
Houston, TX 77030Phone+1 713-799-9997Fax+1 713-799-2511
Education & Training
- UPMC Medical EducationFellowship, Infectious Disease, 2006 - 2008
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2003 - 2006
- Gandhi Medical CollegeClass of 1999
Certifications & Licensure
- TX State Medical License 2022 - 2025
- OH State Medical License 2009 - 2023
- PA State Medical License 2003 - 2009
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infectionsin Adults Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- Pharmacokinetics of cefiderocol in a patient with carbapenem-resistant Acinetobacter baumannii ventriculitis: A case report.Natalie A Finch, Alejandro Granillo, Nazanin Pouya, Adarsh Bhimraj, William R Miller
Pharmacotherapy. 2025-01-01 - Beyond Words: Enhancing Clinical Guideline Comprehension With Icons.Isin Y Comba, John C O'Horo, Joel E Gordon, Yngve Falck-Ytter, Matthew M Moore
Open Forum Infectious Diseases. 2024-11-01 - 2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart f...Adarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, Jonathan Z Li, Lindsey R Baden
Clinical Infectious Diseases. 2024-10-29
Press Mentions
- A Crucial Group of Covid Drugs Has Stopped WorkingFebruary 8th, 2023
- Anti-Inflammatory Agents May Have Role in COVID-19 PneumoniaOctober 25th, 2022
- Ivermectin: Still on a Losing Streak as COVID-19 TreatmentOctober 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: